Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update

Novozymes A/S logo with Basic Materials background

Key Points

  • Short interest in Novozymes A/S increased by 572.8% from the previous month, reaching a total of 54,500 shares as of July 15th.
  • The company's market cap stands at approximately $30.53 billion, with a P/E ratio of 41.26 and a dividend yield of 1.18%.
  • Novozymes A/S produces and sells industrial enzymes and probiotics, offering solutions for various industries including food, beverage, and hygiene.
  • Looking to export and analyze Novozymes A/S data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) saw a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 54,500 shares, anincreaseof572.8% from the June 30th total of 8,100 shares. Based on an average daily volume of 179,000 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 179,000 shares, the short-interest ratio is currently 0.3 days.

Novozymes A/S Trading Down 0.9%

Shares of NVZMY traded down $0.60 during trading hours on Wednesday, hitting $65.49. The stock had a trading volume of 11,733 shares, compared to its average volume of 37,804. The company's fifty day simple moving average is $71.04 and its 200 day simple moving average is $64.25. Novozymes A/S has a 12-month low of $53.95 and a 12-month high of $75.99. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.04 and a current ratio of 1.66. The firm has a market cap of $30.67 billion, a P/E ratio of 41.45, a P/E/G ratio of 1.24 and a beta of 0.90.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Further Reading

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines